(Q40258401)

18 September 2017

title

An engineered antibody-interleukin-12 fusion protein with enhanced tumor vascular targeting properties (English)

1 reference

18 September 2017

Dario Neri

3

0 references

author name string

Verena Gafner

series ordinal

1

1 reference

18 September 2017

Eveline Trachsel

series ordinal

2

1 reference

18 September 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

International Journal of Cancer

18 September 2017

published in

1 reference

18 September 2017

volume

119

1 reference

18 September 2017

issue

9

1 reference

18 September 2017

page(s)

2205-2212

1 reference

Targeted cytokines for cancer immunotherapy.

18 September 2017

cites work

1 reference

Mechanism of antitumor activity of a single-chain interleukin-12 IgG3 antibody fusion protein (mscIL-12.her2.IgG3).

21 January 2018

1 reference

Selective targeted delivery of TNFalpha to tumor blood vessels.

21 January 2018

1 reference

Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature.

21 January 2018

1 reference

Tumour vascular targeting

21 January 2018

1 reference

Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel.

21 January 2018

1 reference

NMR structure of the human oncofoetal fibronectin ED-B domain, a specific marker for angiogenesis

21 January 2018

1 reference

Selective targeting of tumour neovasculature by a radiohalogenated human antibody fragment specific for the ED-B domain of fibronectin

21 January 2018

1 reference

Selective occlusion of tumor blood vessels by targeted delivery of an antibody-photosensitizer conjugate.

21 January 2018

1 reference

Engineering a thermostable human prolyl endopeptidase for antibody-directed enzyme prodrug therapy

21 January 2018

1 reference

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

21 January 2018

1 reference

Interleukin-12 as an adjuvant for cancer immunotherapy

21 January 2018

1 reference

Alkaline Phosphatase Activity in Mouse Teratoma

21 January 2018

1 reference

Radioactive labeling of recombinant antibody fragments by phosphorylation using human casein kinase II and [gamma-32P]-ATP.

21 January 2018

1 reference

An antibody-calmodulin fusion protein reveals a functional dependence between macromolecular isoelectric point and tumor targeting performance.

21 January 2018

1 reference

ED-B fibronectin as a target for antibody-based cancer treatments

21 January 2018

1 reference

Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix

21 January 2018

1 reference

Tumor-targeting properties of antibody-vascular endothelial growth factor fusion proteins

21 January 2018

1 reference

Engineered vascular-targeting antibody-interferon-γ fusion protein for cancer therapy

21 January 2018

1 reference

Selective targeting of tumoral vasculature: Comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin

21 January 2018

1 reference

Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment

21 January 2018

1 reference

Molecular Imaging of Atherosclerotic Plaques Using a Human Antibody Against the Extra-Domain B of Fibronectin

21 January 2018

1 reference

Quantitation of the Tumor-Targeting Properties of Antibody Fragments Conjugated to Cell-Permeating HIV-1 TAT Peptides

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.22101

1 reference

18 September 2017

1 reference